Literature DB >> 26856813

Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.

Z Anastasiadou1, I Schäfer1, J Siebert1, W Günther1, M Reusch2, M Augustin1.   

Abstract

BACKGROUND: In Germany, skin cancer screening was introduced nationwide in July 2008. From the age of 35 years, members of the statutory health insurance are eligible for screening every 2 years.
OBJECTIVE: The aim of this study is to calculate the participation rates and the proportions of health care providers of statutory skin cancer screening in Germany on a population-based level.
METHODS: Data were provided by a nationwide German statutory health insurance, approximately 6.1 million members, covering the years 2008/2009. Participation rates were calculated per yearly quarter and were adjusted for age, gender and federal state.
RESULTS: Approximately 920,000 insurants were screened from the third quarter of 2008 until the last quarter of 2009. Mean participation rate of skin cancer screening was 30.8%. Women had higher participation rates (31.9%) than men (29.7%). After adjusting for gender and federal state, high rates for pensioners at the age of 65-74 were confirmed at 39.4% on average for all yearly quarters. One of the highest gender- and age-adjusted rates was observed in the state of Schleswig-Holstein, where a population based pilot project had been implemented before the start of the nationwide screening programme. In general, without taking into account Berlin, former East Germany had a much lower gender- and age-adjusted participation rate (23.9%) than West Germany (33.3%). At the first quarter after implementation of screening, 58.5% of the screenings were provided by dermatologists and 41.5% by general practitioners.
CONCLUSION: Participation rates and health care providers of skin cancer screening can be calculated from secondary data and contribute to identify group- and region-specific participation patterns in order to improve early detection of skin cancer.
© 2016 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2016        PMID: 26856813     DOI: 10.1111/jdv.13559

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  [Skin cancer screening and treatment costs : Utilisation of the skin cancer screening and skin cancer treatment costs in organ transplant recipients].

Authors:  D Jäckel; N I Schlothauer; H Zeeb; G Wagner; M M Sachse
Journal:  Hautarzt       Date:  2018-07       Impact factor: 0.751

2.  [Primary prevention in the context of skin cancer screening].

Authors:  M Krensel; I Schäfer; N Zander; M Augustin
Journal:  Hautarzt       Date:  2019-06       Impact factor: 0.751

3.  [Regional differences in the health care of basal cell carcinoma].

Authors:  J Augustin; I Schäfer; P Thiess; M Reusch; M Augustin
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

4.  [Early detection of occupational skin diseases in sewer workers].

Authors:  V Lang; F Lauffer; Y Fincan; T Biedermann; A Zink
Journal:  Hautarzt       Date:  2018-09       Impact factor: 0.751

Review 5.  [Risk characteristics and survival rates of malignant melanoma in Germany and the Netherlands].

Authors:  J Augustin; I Schäfer; M Reusch; M Augustin
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

6.  Increasing Participation Rates in Germany's Skin Cancer Screening Program (HELIOS): Protocol for a Mixed Methods Study.

Authors:  Theresa Steeb; Markus V Heppt; Michael Erdmann; Anja Wessely; Stefanie J Klug; Carola Berking
Journal:  JMIR Res Protoc       Date:  2021-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.